A Survey of Acceptance and Factors Associated With Hesitancy Vaccination in Northeast Brazil
NCT06675721 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 2500
Last updated 2024-11-05
Summary
The objective of this study is to investigate vaccination acceptance and identify the reasons why people are not vaccinated.
People over 18 years of age who live in neighborhoods with socioeconomic vulnerability and with many cases of infectious diseases, as well as health professionals, will respond to a research questionnaire.
Conditions
- Vaccine Hesitancy
- Vaccine Refusal
Interventions
- OTHER
-
Study Questionnaire
A survey questionnaire to assess factors related to vaccination adherence, including factors such as vaccine novelty, cost, and prior knowledge among vulnerable populations.
Sponsors & Collaborators
-
MSD Pharmaceuticals LLC
collaborator INDUSTRY -
Centro De Estudos E Pesquisas Em Molestias Infecciosas
lead OTHER
Principal Investigators
-
Kleber G Luz, PhD · Centro De Estudos E Pesquisas Em Molestias Infecciosas
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-12-31
- Primary Completion
- 2025-12-31
- Completion
- 2025-12-31
More Related Trials
-
Measles Vaccination at Health System Contacts
NCT04220671 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Barriers and Facilitators to MMR Vaccination Among Healthcare Workers
NCT06456788 ·Status: COMPLETED
-
Study on COVID-19 Vaccine Effectiveness Among Health Workers in Azerbaijan
NCT05069454 ·Status: UNKNOWN ·Phase: NA
-
BCG to Reduce Absenteeism Among Health Care Workers During the COVID-19 Pandemic
NCT04641858 ·Status: COMPLETED ·Phase: PHASE4
-
BCG Vaccination Delivered Intradermally, Orally and by Combined Routes
NCT00396370 ·Status: COMPLETED ·Phase: PHASE1
-
Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)
NCT01830257 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian Volunteers
NCT00423839 ·Status: COMPLETED ·Phase: PHASE1
-
Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed
NCT05592756 ·Status: COMPLETED
-
Phase 1 ID93 + GLA-SE Vaccine Trial in BCG-Vaccinated Healthy Adult Volunteers
NCT01927159 ·Status: COMPLETED ·Phase: PHASE1
-
A Tool Kit to Improve Vaccine Confidence in the Philippines
NCT06218368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Role of BCG Vaccine in the Clinical Evolution of COVID-19 and in the Efficacy of Anti-SARS-CoV-2 Vaccines
NCT05507671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Bacillus Calmette-Guerin (BCG) Vaccine and Morbidity From Malaria
NCT00131794 ·Status: COMPLETED ·Phase: PHASE3
-
Pertussis Immunization Programs in Low Income Countries - Ivory Coast
NCT03388034 ·Status: COMPLETED
-
Intervention to Promote Childhood Vaccinations and Influence Vaccination Attitudes
NCT05425823 ·Status: COMPLETED ·Phase: NA
-
Measles Vaccine: Is There a Protective Role in COVID 19 Pandemic?
NCT04445610 ·Status: UNKNOWN
-
A Study of GC3107(BCG Vaccine) in Healthy Infants
NCT03947138 ·Status: COMPLETED ·Phase: PHASE3
-
Risk of COVID-19 Infection After Vaccination
NCT04848441 ·Status: UNKNOWN
-
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
NCT04658680 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau
NCT02953327 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study of BCG Vaccine for Intradermal Injection
NCT04563273 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Effects of BCG Vaccination on Infectious and Immune Mediated Diseases
NCT05387655 ·Status: ACTIVE_NOT_RECRUITING
-
A Second Dose of Measles Vaccine (MV) in the Second Year of Life
NCT02943681 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of the BNT162b2 Covid-19 Vaccine in Elderly People Aged 85 and Older in Greece
NCT04756817 ·Status: COMPLETED
-
Immunisation History Survey - a Study to Measure Levels of Immunity to Routine Immunisations
NCT03145324 ·Status: COMPLETED
-
Measles Vaccine in HCW
NCT04357028 ·Status: SUSPENDED ·Phase: PHASE3